MedPath

Multi-center and Multi-modal Deep Learning Study of Gastric Cancer

Active, not recruiting
Conditions
Stomach Neoplasms
Interventions
Radiation: The whole abdomen contrast-enhanced CT scan
Other: H&E stained sections and slides
Registration Number
NCT05001321
Lead Sponsor
First Hospital of China Medical University
Brief Summary

To assist postoperative pathological diagnosis and classification of gastric cancer by machine learning; To improve the accuracy of pathological diagnosis of gastric cancer by machine learning; To predict the effectiveness of treatment for gastric cancer by deep learning; To construct a model to predict the survival of gastric cancer patients by multimodal deep learning.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
3300
Inclusion Criteria
  • The diagnosis of gastric cancer was confirmed by pathology;
  • Preoperative enhanced abdominal CT;
  • Available detailed clinical and pathological data;
  • Integrated follow-up data.
Exclusion Criteria
  • The patients had severe underlying disease;
  • Overall survival was less than 3 months;
  • No detailed information could be collected.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Training GroupThe whole abdomen contrast-enhanced CT scanBased on the inclusion criteria, 2000 gastric cancer patients will be recruited in the analysis. And a model will be constructed based on deep learning.
Internal Validation GroupH&E stained sections and slidesBased on the inclusion criteria, 1000 gastric cancer patients will be recruited in this group to verify the sensitivity and specificity of the constructed model.
External Validation GroupH&E stained sections and slidesBased on the inclusion criteria, 300 gastric cancer patients from 5 other medical centers will be recruited in this group to verify the sensitivity and specificity of the constructed model.
Training GroupH&E stained sections and slidesBased on the inclusion criteria, 2000 gastric cancer patients will be recruited in the analysis. And a model will be constructed based on deep learning.
Internal Validation GroupThe whole abdomen contrast-enhanced CT scanBased on the inclusion criteria, 1000 gastric cancer patients will be recruited in this group to verify the sensitivity and specificity of the constructed model.
External Validation GroupThe whole abdomen contrast-enhanced CT scanBased on the inclusion criteria, 300 gastric cancer patients from 5 other medical centers will be recruited in this group to verify the sensitivity and specificity of the constructed model.
Primary Outcome Measures
NameTimeMethod
Growth pattern1 day

To assess the growth pattern on preoperative enhanced abdominal CT of patients with gastric cancer, including endophytic, exophytic and mixed.

Nucleus shape1 day

To obtain the nucleus shape of postoperative H\&E stained sections and slides of gastric cancer by deep learning.

Enhancement pattern1 day

To assess the enhancement pattern on preoperative enhanced abdominal CT of patients with gastric cancer, including homogeneous and heterogeneous.

Maximum diameter of tumor1 day

To measure the maximum diameter of tumor on preoperative enhanced abdominal CT of patients with gastric cancer.

Enhancement degree1 day

To assess the enhancement degree on preoperative enhanced abdominal CT of patients with gastric cancer, including hypoenhancement, isoenhancement and hyperenhancement.

Nucleus size1 day

To obtain the nucleus size of postoperative H\&E stained sections and slides of gastric cancer by deep learning.

Distribution of pixel intensity1 day

To obtain the distribution of pixel intensity of postoperative H\&E stained sections and slides of gastric cancer by deep learning.

Texture of nuclei1 day

To obtain the texture of nuclei of postoperative H\&E stained sections and slides of gastric cancer by deep learning.

Secondary Outcome Measures
NameTimeMethod
Survival status1 day

To analyze the survival status of patients with gastric cancer, involving dead and alive.

Recurrence/metastasis1 day

To calculate the days to recurrence/metastasis of patients with gastric cancer.

Overall survival1 day

To calculate the overall survival of patients with gastric cancer based on days to death and days to last follow-up.

Trial Locations

Locations (6)

The fourth People's Hospital of Changzhou

🇨🇳

Changzhou, Jiangsu, China

Chaoyang Central Hospital

🇨🇳

Chaoyang, Liaoning, China

The General Hospital of Fushun Mining Bureau

🇨🇳

Fushun, Liaoning, China

First Hospital of Jinzhou Medical University

🇨🇳

Jinzhou, Liaoning, China

The First Affiliated Hospital of China Medical University

🇨🇳

Shenyang, Liaoning, China

The Second Hospital of Shandong University

🇨🇳

Ji'nan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath